Caption Management, LLC Rhythm Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$40.81 - $55.0 $5.75 Million - $7.74 Million	140,800 Added 281.6%	190,800 $10 Million
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $13.1 Million - $16.4 Million	-369,300 Reduced 88.08%	50,000 $2.05 Million
Q1 2024 May 15, 2024	SELL	$39.12 - $52.44 $2.05 Million - $2.75 Million	-52,400 Reduced 11.11%	419,300 $18.2 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $10.1 Million - $23.4 Million	471,700 New	471,700 $21.7 Million
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $50,004 - $60,885	-2,700 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $48,951 - $82,647	2,700 New	2,700 $58,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.11B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.